La bourse ferme dans 5 h 47 min
  • CAC 40

    5 537,38
    -53,41 (-0,96 %)
     
  • Euro Stoxx 50

    3 589,13
    -29,22 (-0,81 %)
     
  • Dow Jones

    31 176,01
    -12,37 (-0,04 %)
     
  • EUR/USD

    1,2179
    +0,0006 (+0,05 %)
     
  • Gold future

    1 852,90
    -13,00 (-0,70 %)
     
  • BTC-EUR

    25 721,49
    +664,07 (+2,65 %)
     
  • CMC Crypto 200

    619,85
    +9,86 (+1,62 %)
     
  • Pétrole WTI

    51,87
    -1,26 (-2,37 %)
     
  • DAX

    13 828,43
    -78,24 (-0,56 %)
     
  • FTSE 100

    6 679,76
    -35,66 (-0,53 %)
     
  • Nasdaq

    13 530,92
    0,00 (0,00 %)
     
  • S&P 500

    3 853,07
    +1,22 (+0,03 %)
     
  • Nikkei 225

    28 631,45
    -125,41 (-0,44 %)
     
  • HANG SENG

    29 447,85
    -479,91 (-1,60 %)
     
  • GBP/USD

    1,3663
    -0,0067 (-0,49 %)
     

Global Systemic Lupus Erythematosus (Sle) Drugs Industry

ReportLinker
·7 min de lecture

Global Systemic Lupus Erythematosus (Sle) Drugs Market to Reach US$264. 5 Million by the Year 2027. Amid the COVID-19 crisis, the global market for Systemic Lupus Erythematosus (Sle) Drugs estimated at US$183.

New York, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Systemic Lupus Erythematosus (Sle) Drugs Industry" - https://www.reportlinker.com/p05960224/?utm_source=GNW
3 Million in the year 2020, is projected to reach a revised size of US$264.5 Million by 2027, growing at a CAGR of 5.4% over the period 2020-2027.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5% CAGR for the Period of 2020-2027

The Systemic Lupus Erythematosus (Sle) Drugs market in the U.S. is estimated at US$54 Million in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$46.6 Million in the year 2027 trailing a CAGR of 5% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR while Rest of European market (as defined in the study) will reach US$46.6 Million by the year 2027.We bring years of research experience to this 8th edition of our report. The 105-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Amgen, Inc.

  • Bristol-Myers Squibb Company

  • GlaxoSmithKline PLC

  • Immunomedics, Inc.

  • Johnson & Johnson

  • MedImmune LLC

  • Merck Serono GmbH

  • Sanofi SA

  • Teva Pharmaceutical Industries Ltd.

  • UCB SA




Read the full report: https://www.reportlinker.com/p05960224/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Systemic Lupus Erythematosus (Sle) Drugs Competitor Market
Share Scenario Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 2: World Historic Review for Systemic Lupus Erythematosus
(Sle) Drugs by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 3: World 15-Year Perspective for Systemic Lupus
Erythematosus (Sle) Drugs by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2012, 2018 &
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Table 4: USA Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 5: USA Historic Review for Systemic Lupus Erythematosus
(Sle) Drugs by Segment - Systemic Lupus Erythematosus (Sle)
Drugs Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

CANADA
Table 6: Canada Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 7: Canada Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

JAPAN
Table 8: Japan Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 9: Japan Historic Review for Systemic Lupus Erythematosus
(Sle) Drugs by Segment - Systemic Lupus Erythematosus (Sle)
Drugs Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

CHINA
Table 10: China Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 11: China Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

EUROPE
Table 12: Europe Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 13: Europe Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 14: Europe 15-Year Perspective for Systemic Lupus
Erythematosus (Sle) Drugs by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK and
Rest of Europe Markets for Years 2012, 2018 & 2027

FRANCE
Table 15: France Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 16: France Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

GERMANY
Table 17: Germany Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 18: Germany Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

ITALY
Table 19: Italy Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 20: Italy Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 22: UK Historic Review for Systemic Lupus Erythematosus
(Sle) Drugs by Segment - Systemic Lupus Erythematosus (Sle)
Drugs Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

REST OF EUROPE
Table 23: Rest of Europe Current & Future Analysis for Systemic
Lupus Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 24: Rest of Europe Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

ASIA-PACIFIC
Table 25: Asia-Pacific Current & Future Analysis for Systemic
Lupus Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 26: Asia-Pacific Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

REST OF WORLD
Table 27: Rest of World Current & Future Analysis for Systemic
Lupus Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs - Independent Analysis of Annual
Sales in US$ Million for the Years 2018 through 2027

Table 28: Rest of World Historic Review for Systemic Lupus
Erythematosus (Sle) Drugs by Segment - Systemic Lupus
Erythematosus (Sle) Drugs Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2017

IV. COMPETITION
Total Companies Profiled: 41
Read the full report: https://www.reportlinker.com/p05960224/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001